Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
141
Publications avec texte intégral
Open Access
53 %
Mots clés
Heart
Thérapie génique
Aging
Centronuclear myopathy
CTG repeats
CMS
Glucocorticoid-receptor
PCR
Exercise
RNA splicing
Astrocyte
Knockout
PacBio
CTG repeat instability
Cytoskeleton
Myostatin
Cardiac muscle
Humans
Fibrosis
Motoneuron
Myelin
RNA interference
Oligodendrocytes
Trinucleotide repeat expansion
Heart failure
Neuron
Gene Therapy
Transgenic mouse model
Hypoxia
Brain
Antisense oligonucleotide
Antisense oligonucleotides
Muscular dystrophy
Intermediate filament
Animals
GSK3
Glutamate
RNA biology
Glial cells
Therapy
Male
Endurance training
AAV
Exercice
Expression
DMPK
KNOCKOUT MICE
Myotonic Dystrophy
Autophagy
Long read sequencing
Myotonic dystrophy mouse models
CRISPR/Cas9
Muscle
Cell culture model
Dynamin 2
Central nervous system
Dilated cardiomyopathy
Duchenne muscular dystrophy
Quantitative microdialysis
GABA
Acute coronary syndrome
Dystrophin
Myotonic dystrophy
CTG repeat contractions
Gene editing
DMSXL mice
Myotonic dystrophy type 1
Acetylcholinesterase deficiency
Acetylcholinesterase knockout mouse
Skeletal muscle
Myotonic Dystrophy type 1
Dystrophie Myotonique
In vivo
CONGENITAL MYATHENIC SYNDROME
Dystrophie myotonique
Oligodendrocyte
CRISPRi
BIOLOGIE MOLECULAIRE
Gene therapy
Genotype phenotype correlation
DM1
MBNL
Mouse models
ACETYLCHOLINESTERASE
Myotonic Dystrophy Type 1
Desmin
Cell model
Diaphragm
Brain dysfunction
Glucocorticoids
Transgenic mouse
Trinucleotide Repeat Expansion
ARN
Alternative splicing
Mice
Transcriptomics
Maximal force
Cell penetrating peptide
Mouse model
Astrocytes